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Abstract
Mammals are co-infected by multiple pathogens that interact through unknown mechanisms. We 
found that helminth infection, characterized by the induction of the cytokine interleukin-4 (IL-4) 
and the activation of the transcription factor Stat6, reactivated murine gammaherpesvirus infection 
in vivo. IL-4 promoted viral replication and blocked the antiviral effects of interferon-γ (IFNγ) by 
inducing Stat6 binding to the promoter for an important viral transcriptional transactivator. IL-4 
also reactivated human Kaposi's sarcoma associated herpesvirus from latency in cultured cells. 
Exogenous IL-4 plus blockade of IFNγ reactivated latent murine gammaherpesvirus infection in 
vivo, suggesting a ‘two-signal’ model for viral reactivation. Thus chronic herpesvirus infection, a 
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component of the mammalian virome, is regulated by the counterpoised actions of multiple 
cytokines on viral promoters that have evolved to sense host immune status.
Mammals are populated by many chronic viruses, termed the virome, which can regulate 
host physiology and disease susceptibility(1). For example, more than 90% of humans are 
latently infected with herpesviruses that, after clearance of acute infection, produce little 
infectious virus and often cause no overt disease. Like human gammaherpesviruses Epstein 
Barr Virus (EBV) and Kaposi’s sarcoma associated herpesvirus (KSHV), murine 
gammaherpesvirus-68 (MHV68) establishes lifelong latency. Studies in this model system 
showed that the cytokine IFNγ nhibits MHV68 replication and reactivation from 
macrophages, a major cellular site for latency(2–5), controls persistent replication in vivo(6), 
and is present at low amounts during latency(7).
Many people around the world are co-infected with herpesviruses and intestinal helminths. 
While herpesviruses can modulate immunity to harm or benefit the host(7–11), the effects of 
helminth co-infection on chronic herpesvirus infection are unexplored. Intestinal helminths 
generate strong T helper 2 (Th2)-driven cytokine responses, which counter the biological 
effects of IFNγ, and drive the activation of macrophages with an M2 (immunoregulatory) 
rather than an M1 (pro-inflammatory) phenotype(12). Parasitic worms may influence control 
of pathogens, including Mycobacterium tuberculosis, HIV, and Plasmodium species in 
humans, but there are few studies elucidating the mechanisms behind this 
immunomodulation(13). Thus, we considered the hypothesis that parasite infection would 
induce MHV68 reactivation in vivo.
We examined the effects of acute infection with Heligmosomoides polygyrus or 
Schistosomiasis mansoni (Sm) egg administration on MHV68 reactivation from latency 
using a MHV68 virus expressing luciferase under the control of a lytic viral promoter upon 
reactivation from latency in vivo (MHV68-M3-FL)(14). Both acute H. polygyrus infection 
and Sm egg challenge reactivated MHV68 infection (Fig. 1A–D). Mice latently infected for 
over 100 days also showed increased luciferase expression following Sm egg challenge (fig. 
S1). By contrast, infection with the systemic bacteria, Listeria monocytogenes, did not 
stimulate viral reactivation (fig. S2). Thus, responses to either a nematode parasite or 
trematode eggs induced herpesvirus reactivation, suggesting a role for Th2 cytokines in viral 
reactivation.
To determine whether Th2 cytokines affect latently infected macrophages we compared host 
gene expression patterns in virally infected and uninfected macrophages during chronic 
infection. We engineered MHV68 to express cre-recombinase (MHV68-cre) from a locus 
permitting heterologous gene expression without altering viral replication or reactivation(15) 
(fig. S3). Reporter mice in which fluorescent protein expression is induced by cre 
recombination (Rosa26-floxed stop-eYFP or tandem dimer (td)RFP(16)) were infected with 
MHV68-cre. Virus-positive and virus-negative cells sorted from latently infected mice (fig. 
S3G) were subjected to RNAseq analysis. Transcription in these cells was compared to that 
in bone marrow-derived macrophages (BMDMs) stimulated with IL-4 (M2) or IFNγ plus 
lipopolysaccharide (LPS) (M1). compared to untreated BMDMs (M0). Gene set enrichment 
analysis (GSEA) revealed that genes upregulated in M1 BMDMs were enriched in virus-
Reese et al. Page 2









positive macrophages whereas genes upregulated in M2 BMDMs were enriched in virus-
negative cells (Fig. 2A, and table S1). This was consistent with the role of IFNγ, which 
drives M1 macrophage polarization, in inhibiting MHV68 replication and reactivation(3, 4). 
We therefore tested whether latent MHV68 infection was restricted to M1-type macrophages 
by infecting tandem dimer (td)RFP mice carrying the Arginase-1 (Arg1)-YFP reporter 
(YARG, a marker for macrophages stimulated with Th2 cytokines)(17) with MHV68-cre. 
Surprisingly, virus-positive macrophages were either Arg1-negative or Arg1-positive (Fig. 
2B, C), suggesting that, despite the role for IFNγ in controlling chronic MHV68 infection, at 
least some virus-infected cells were exposed to cytokines that drive Arg-1 expression in 
vivo.
The presence of an IL-4 signature in some virus-infected macrophages along with the 
observation that Th2 cytokine-inducing parasites promoted reactivation from latency, 
suggested a role for IL-4 in viral infection. We tested this by determining the effect of IL-4 
on MHV68 replication in BMDMs. Treatment with IL-4 increased Arg1 expression (fig. 
S4A) consistent with M2 polarization(18). As expected, few infected BMDMs expressed 
lytic viral antigens upon MHV68 infection(19). However, IL-4 pretreatment increased the 
number of BMDMs expressing viral proteins and enhanced viral replication (Fig. 3A, fig. 
S4B–D), and increased infection of transformed RAW264.7 macrophages (fig. S4E). 
Treatment with IL-4 after MHV68 infection increased viral replication (fig. S4F), indicating 
that IL-4 acts on replication rather than by increasing the number of infected cells. 
Enhancement of replication was dependent on the Th2-associated transcription factor Stat6 
(Fig. 3A), and occurred with IL-13 stimulation, another Th2-associated cytokine that utilizes 
the IL-4 receptor α chain and signals via Stat6 (Fig. 3B, fig. S4D, G). The Th2 cytokine 
IL-5, which does not signal through Stat6, did not promote MHV68 replication (Fig. 3B).
After treatment with IL-4, the majority of infected cells did not express the M2 markers 
CD206 or Arg1 (Fig. 3A, and fig. S4A), suggesting that not all IL-4-induced changes in 
macrophage differentiation are required for enhanced MHV68 replication(20). Etomoxir 
blocks IL-4-induced changes in fatty–acid oxidation(21) and upregulation of CD206 (fig. 
S5A) but did not block enhancement of MHV68 replication by IL-4 (fig. S5B). Moreover, 
IL-4 enhanced replication in the absence of PPARγ or ARG1, key proteins involved in M2 
macrophage function, or iNOS, an essential protein in M1 macrophage function (fig. S5C–
G)(20). Importantly, IL-4 antagonized IFNγ-mediated suppression of viral replication (Fig. 
3C)(3). Because Stat6 antagonizes Stat1(22), we tested whether IL-4 promoted virus 
replication in the absence of Stat1. IL-4 increased virus replication in Stat1-deficient 
BMDMs (fig. S6).
Previously, we found that IFNγ-mediated suppression of viral replication was associated 
with inhibition of promoters driving expression of the essential viral latent-to-lytic switch 
gene (gene 50) (3, 23). Importantly, IL-4 antagonizes IFNγ-mediated suppression of gene 50 
transcription (Fig. 3D). This effect was specific to the viral promoter because IL-4 did not 
block IFNγ-mediated induction of Nos2, and IFNγ did not inhibit IL-4-mediated induction 
of Arg1 and Relmα/Fizz1 (fig S7). Furthermore, IL-4 and IL-13 transactivated the gene 50 
N4/N5 promoter (Fig. 3E)(24), and IL-4 antagonized IFNγ-mediated suppression of N4/N5 
promoter (Fig. 3F). The effect of IL-4 on the N4/N5 promoter was diminished by mutation 
Reese et al. Page 3









of two of four putative Stat-binding sites in the promoter (Fig. 3G, fig. S8). Further, 
chromatin immunoprecipitation experiments revealed that Stat6 bound to the N4/N5 
promoter after IL-4 treatment of MHV68-infected cells (Fig. 3H). Taken together, these data 
suggest that activated Stat6 induced by IL-4/IL-13 promotes viral replication by binding to 
and acting on a viral promoter to induce expression of gene 50.
These counterbalancing effects of IFNγ and IL-4 on virus replication and viral promoter 
activity suggested a potential mechanism by which IL-4-inducing pathogens such as 
helminths promote reactivation. We therefore treated mice infected with MHV68-M3-FL 
virus with a blocking antibody to IFNγ (clone H22)(25), an isotype control antibody (clone 
PIP), long-lasting IL-4 complexes (IL4c)(26), or a combination of anti IFNγ and IL4c. No 
reactivation was observed after treatment with anti-IFNγ, IL4c, or PIP alone, indicating that 
a single signal was insufficient to reactivate virus in vivo. However, robust reactivation was 
observed in mice that received a combination of IL-4c and anti-IFNγ (Fig. 4A, B, fig. S9A). 
We next assayed reactivation using an independent assay(27, 28). Little or no preformed 
virus was detectable in tissues after treatment with PIP, IL4c, or anti-IFNγ alone(27), while 
treatment with IL-4c plus anti-IFNγ increased infectious virus (fig. S9B, C). Together these 
data supports a 'two-signal' mechanism by which co-infections could induce reactivation via 
induction of IL-4 and inhibition of Th1 responses(12).
Increased reactivation after treatment with both IL4c/anti-IFNγ required Stat6 (Fig. 4C). We 
did not test the role of Stat1 or the IFNγ receptor because both are required to establish 
latency(6). To assess whether the effects of helminth infection on MHV68 reactivation also 
required Stat6, we challenged MHV68-infected Stat6KO mice with H. polygyrus. We found 
that helminth infection did not reactivate MHV68 from latency in Stat6KO mice, further 
supporting a two-signal model for control of gammaherpesvirus reactivation in vivo (Fig.
4D).
Our results suggested a possible role for IL-4 in human gammaherpesvirus reactivation. We 
therefore tested whether IL-4 could reactivate the human gammaherpesvirus, KSHV in the 
BCBL-1 human B cell lymphoma cell line. We found that treatment with IL-4 increased 
immediate early (RTA, ORF45, and ORF57) and late viral transcripts (ORF19) (29)(Fig. 
4E). RTA is the homolog in KSHV of MHV68 gene50, and ORF 45 and ORF57 are both 
transactivators, indicating a common role of IL-4 in regulating important viral 
transcriptional transactivators. Furthermore, IL-4 treatment of cells increased virus 
production (Fig. 4F), indicating that IL-4 is capable of inducing reactivation of KSHV.
A remarkable aspect of herpesvirus infection is its permanence despite ongoing immunity 
combined with the capacity to reactivate and spread to new hosts. This work illuminates one 
potential mechanism by which a gammaherpesvirus exhibits these two apparently disparate 
functions. Our data suggest that the virus evolved cytokine-responsive promoters to remain 
latent under some conditions (IFNγ-dominant) while reactivating under other conditions 
(IL-4-dominant). In this setting, co-infection may govern the outcome of reactivation by 
changing the balance in IL-4 and IFNγ, thus raising a potential issue with herpesvirus 
reactivation and proposed live helminth therapies(12). Additionally, our data illustrate one 
potential mechanism by which helminths and other Type 2 immune response-inducing 
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parasites influence host control of another pathogen through M2 macrophage 
polarization(13). The fact that viral promoters for an essential gene are responsive to host 
cytokines implies that the viral genome evolved to sense the infection status of the host. We 
speculate that a similar mechanism for IL-4-induced reactivation of KSHV could also be 
true. Although not extensively studied, seroprevalence to KSHV is associated with 
hookworm and other parasitic infections in Uganda(30). Intriguingly, certain Burkitt’s 
lymphoma cell lines are reported to express EBV transcripts in response to IL-4(31).
Although mouse studies are done in specific pathogen-free animals, our data suggest that 
there is added complexity when multiple pathogens infect the same host, particularly in 
situations where one pathogen has the capacity to respond to specific immune signals 
generated to another pathogen to regulate chronic infection. Previously we showed that 
herpesvirus infection, a component of the mammalian virome(1) enhances resistance to 
some pathogens(7). Here we demonstrate the opposite effect, that co-infection regulates 
herpesvirus reactivation. These studies emphasize that immunity to chronic infection is a 
dynamic equilibrium regulated by co-infections, in part through highly evolved pathogen 
genomes with the capacity to sense host cytokines.
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Fig. 1. Challenge with H. polygyrus and S. mansoni eggs reactivates MHV68
(A) C57BL6/J mice were infected intraperitoneally (i.p.) with MHV68-M3-FL and 
challenged with H. polygyrus 42 days later. Mice were imaged prior to H. polygyrus 
infection (day 0) and 5, 7 and 9 days after. Three representative mice imaged on days 0 and 
7 are shown. (B) Total flux (photons/second) was quantitated for mice in 2 independent 
experiments for the timecourse after infection with H. polygyrus. Data from 4 independent 
experiments at day 7 post H. polygyrus is also shown. (C) C57BL/6J mice were infected 
intranasally (i.n.) with MHV68-M3-FL. Diagram indicates timecourse of experiment and 
challenge with Sm eggs or PBS as a control. Mice were injected with D-Luciferin and 
imaged prior to intravenous (i.v.) challenge with Sm eggs (day 0). They were subsequently 
imaged 5, 8 and 11 days after challenge with Sm eggs. Three representative mice imaged on 
days 0 and 8 are shown. (D) Total flux (photons/second) was quantitated from mice in two 
independent experiments after Sm egg challenge. Symbols represent individual mice, and the 
mean and standard error are indicated * p<0.05, ** p<0.01, *** p<0.001 by 2-way repeated 
measures ANOVA with Tukey’s and Bonferroni’s post-test.
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Fig. 2. IL-4 and IFNγ signatures identified in different macrophage populations during MHV68 
infection
(A) GSEA analysis of virus-positive and virus-negative cells sorted from the peritoneum of 
MHV68-infected mice compared to BMDMs stimulated with IL-4 or IFNγ/LPS. (B) 
C57BL/6J mice or YARG/R26-stop-RFP mice were either mock infected or infected with 
MHV68-cre. CD11b+F4/80+ cells were gated and examined for RFP and YFP expression. 
Representative plots from two independent experiments, with three to five mice per 
experiment. (C) Quantitation of FACS analysis in (B) with each symbol representing a 
single mouse.
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Fig. 3. IL-4 promotes viral replication and antagonizes IFNγ suppression of viral replication 
through direct binding to a viral promoter
(A) BMDMs were untreated or treated with the indicated doses of IL-4 and infected with 
MHV68. 24 hours post infection cells were analyzed for expression of MHV68 lytic viral 
proteins and CD206 expression. Represents three independent experiments. (B) Pretreatment 
of BMDMs with IL-4, IL-13, or IL-5 prior to infection with MHV68 and FACS analysis. 
(C) BMDMs were pretreated with varying doses of IFNγ ± 10 ng/ml of IL-4. 24 hours post 
infection cells were analyzed for expression of lytic viral proteins. Represents three 
independent experiments. (D) Gene 50 expression was analyzed by RT-PCR in BMDMs 
pretreated with IL-4 and/or IFNγ. Expression was normalized to Gapdh. Represents four 
independent experiments. (E) RAW264.7 cells were transfected with vectors expressing 
luciferase under control of four different gene 50 promoters ((23, 24). Cells were then 
treated ± IL-4 or IL-13 for 24 hours, lysed and assayed for luciferase activity. (F) Cells were 
transfected with the N4/N5 promoter luciferase construct and treated with IL-4, IFNγ, or 
both. (G) N4/N5 luciferase mutants were transfected into RAW264.7 cells and assayed for 
sensitivity to IL-4. (H) RAW264.7 cells were infected with MHV68 at MOI=5 and treated 
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with IL-4 for 8 hours. After chromatin immunoprecipitation with Stat6 antibody, 
quantitative PCR was performed for the N4/N5 promoter region or VEGF. Percent of input 
after normalizing to IgG control was calculated for both N4/N5 and VEGF. 1 experiment 
representative of 4 independent experiments is shown. (I) Schematic of N4/N5 luciferase 
construct with potential Stat-binding mutants. n.d. not detected. n.s. not significant. * 
p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001 by T test or 1-way ANOVA with Sidak’s 
multiple comparisons test.
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Fig. 4. MHV68 and KSHV reactivation from latency is regulated by IL-4
(A) C57BL6/J mice were infected with MHV68-M3-FL i.p. 42 days later mice were imaged 
for luciferase expression (d0) and then received isotype control (PIP), anti-IFNγ (H22), 
IL4c, or both anti-IFNγ and IL-4c. On day 44 mice received a second dose of IL4c or PBS. 
Mice were imaged five days after the first treatment and total flux from the abdominal 
region was quantitated. Four representative mice are shown. (B) Quantitation of total flux 
from three individual experiments described in (A) are shown. Each symbol represents an 
individual mouse. Bars are means, and error bars are standard errors. (C) WT or Stat6KO 
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mice were treated as in (A) with anti-IFNγ/IL4c and imaged 5 days later. Bars are the means 
of individual mice (symbols), and error bars are standard error. (D) Experimental set-up was 
the same as Fig. 1A. Latently infected WT and Stat6KO mice infected with MHV68-M3-FL 
were infected with H. polygyrus or treated with PBS on day 42 and reactivation was 
quantitated by luciferase induction 7 days later. (E) BCBL-1 cells were treated with IL-4 for 
3 or 5 days or TPA for 48 hours and viral gene expression was analyzed. Shown is the fold 
increase in gene expression over mock after normalization of GAPDH. Data from 3 
independent experiments. (F) Supernatants from cells treated in (E) were collected and virus 
was isolated by centrifugation. Viral genome copy number was assayed by qPCR using 
serial diluted LANA expression plasmid as a standard curve. 1 experiment representative of 
2 independent experiments is shown. For luciferase experiments: * p<0.05, ** p<0.01, n.s. 
not significant by 2-way repeated measures ANOVA with Tukey’s and Bonferroni’s post-
test.
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